208 related articles for article (PubMed ID: 7585585)
1. Mechanism of action of chemoprotective ursodeoxycholate in the azoxymethane model of rat colonic carcinogenesis: potential roles of protein kinase C-alpha, -beta II, and -zeta.
Wali RK; Frawley BP; Hartmann S; Roy HK; Khare S; Scaglione-Sewell BA; Earnest DL; Sitrin MD; Brasitus TA; Bissonnette M
Cancer Res; 1995 Nov; 55(22):5257-64. PubMed ID: 7585585
[TBL] [Abstract][Full Text] [Related]
2. Chemoprevention of azoxymethane-induced colonic carcinogenesis by supplemental dietary ursodeoxycholic acid.
Earnest DL; Holubec H; Wali RK; Jolley CS; Bissonette M; Bhattacharyya AK; Roy H; Khare S; Brasitus TA
Cancer Res; 1994 Oct; 54(19):5071-4. PubMed ID: 7923119
[TBL] [Abstract][Full Text] [Related]
3. Effect of amount and types of dietary fat on intestinal bacterial 7 alpha-dehydroxylase and phosphatidylinositol-specific phospholipase C and colonic mucosal diacylglycerol kinase and PKC activities during stages of colon tumor promotion.
Reddy BS; Simi B; Patel N; Aliaga C; Rao CV
Cancer Res; 1996 May; 56(10):2314-20. PubMed ID: 8625306
[TBL] [Abstract][Full Text] [Related]
4. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.
Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057
[TBL] [Abstract][Full Text] [Related]
5. Ursodeoxycholic acid inhibits the initiation and postinitiation phases of azoxymethane-induced colonic tumor development.
Wali RK; Stoiber D; Nguyen L; Hart J; Sitrin MD; Brasitus T; Bissonnette M
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1316-21. PubMed ID: 12433708
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase C isoforms in the chemopreventive effects of a novel vitamin D3 analogue in rat colonic tumorigenesis.
Wali RK; Bissonnette M; Khare S; Aquino B; Niedziela S; Sitrin M; Brasitus TA
Gastroenterology; 1996 Jul; 111(1):118-26. PubMed ID: 8698190
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon.
Rao CV; Desai D; Simi B; Kulkarni N; Amin S; Reddy BS
Cancer Res; 1993 Sep; 53(18):4182-8. PubMed ID: 8364913
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase C isoforms in human and rat colonic mucosa.
Davidson LA; Jiang YH; Derr JN; Aukema HM; Lupton JR; Chapkin RS
Arch Biochem Biophys; 1994 Aug; 312(2):547-53. PubMed ID: 8037470
[TBL] [Abstract][Full Text] [Related]
9. 1 alpha,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol, a noncalcemic analogue of 1 alpha,25-dihydroxyvitamin D3, inhibits azoxymethane-induced colonic tumorigenesis.
Wali RK; Bissonnette M; Khare S; Hart J; Sitrin MD; Brasitus TA
Cancer Res; 1995 Jul; 55(14):3050-4. PubMed ID: 7606726
[TBL] [Abstract][Full Text] [Related]
10. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
11. Protein Kinase-zeta inhibits collagen I-dependent and anchorage-independent growth and enhances apoptosis of human Caco-2 cells.
Mustafi R; Cerda S; Chumsangsri A; Fichera A; Bissonnette M
Mol Cancer Res; 2006 Sep; 4(9):683-94. PubMed ID: 16940160
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of PLK3 gene expression by types and amount of dietary fat in rat colon tumors.
Dai W; Liu T; Wang Q; Rao CV; Reddy BS
Int J Oncol; 2002 Jan; 20(1):121-6. PubMed ID: 11743651
[TBL] [Abstract][Full Text] [Related]
13. Ursodeoxycholic acid suppresses Cox-2 expression in colon cancer: roles of Ras, p38, and CCAAT/enhancer-binding protein.
Khare S; Mustafi R; Cerda S; Yuan W; Jagadeeswaran S; Dougherty U; Tretiakova M; Samarel A; Cohen G; Wang J; Moore C; Wali R; Holgren C; Joseph L; Fichera A; Li YC; Bissonnette M
Nutr Cancer; 2008; 60(3):389-400. PubMed ID: 18444174
[TBL] [Abstract][Full Text] [Related]
14. Effect of ursodeoxycholic acid on azoxymethane-induced aberrant crypt foci formation in rat colon: in vitro potential role of intracellular Ca2+.
Momen MA; Monden Y; Houchi H; Umemoto A
J Med Invest; 2002 Feb; 49(1-2):67-73. PubMed ID: 11901763
[TBL] [Abstract][Full Text] [Related]
15. The effect of bile acids and piroxicam on MHC antigen expression in rat colonocytes during colon cancer development.
Rigas B; Tsioulias GJ; Allan C; Wali RK; Brasitus TA
Immunology; 1994 Oct; 83(2):319-23. PubMed ID: 7835954
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity.
Rao CV; Wang CQ; Simi B; Rodriguez JG; Cooma I; El-Bayoumy K; Reddy BS
Cancer Res; 2001 May; 61(9):3647-52. PubMed ID: 11325834
[TBL] [Abstract][Full Text] [Related]
17. Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats.
Kawamori T; Tanaka T; Hara A; Yamahara J; Mori H
Cancer Res; 1995 Mar; 55(6):1277-82. PubMed ID: 7882322
[TBL] [Abstract][Full Text] [Related]
18. Dietary fat and colon cancer: modulating effect of types and amount of dietary fat on ras-p21 function during promotion and progression stages of colon cancer.
Singh J; Hamid R; Reddy BS
Cancer Res; 1997 Jan; 57(2):253-8. PubMed ID: 9000564
[TBL] [Abstract][Full Text] [Related]
19. Ursodeoxycholic acid inhibits translocation of protein kinase C in human colonic cancer cell lines.
Shah SA; Looby E; Volkov Y; Long A; Kelleher D
Eur J Cancer; 2005 Sep; 41(14):2160-9. PubMed ID: 16122920
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of ursodeoxycholic acid on N-methylnitrosourea-induced colon carcinogenesis and colonic mucosal telomerase activity in F344 rats.
Narisawa T; Fukaura Y; Terada K; Sekiguchi H
J Exp Clin Cancer Res; 1999 Jun; 18(2):259-66. PubMed ID: 10464717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
